HealthQuad

HealthQuad is a venture capital firm established in 2016 and based in New Delhi, India. The firm focuses on investing in innovative companies within the healthcare sector, aiming to empower entrepreneurs who are developing unique solutions to transform the prevention and treatment of illnesses. HealthQuad emphasizes a collaborative approach, positioning itself as a strategic partner rather than merely a financial backer. By providing not only capital but also valuable advice, support, and resources, HealthQuad seeks to help entrepreneurs realize their market potential. The firm leverages its extensive expertise, strong network, and rich ecosystem to foster meaningful partnerships that drive growth and innovation in healthcare.

Ajay Mahipal

Director

PINAK SHRIKHANDE

Managing Director

29 past transactions

eKincare

Series C in 2025
eKincare is an AI-powered integrated health benefits platform that delivers preventive, predictive, and personalized healthcare solutions for organizations and their employees. By leveraging technology and analytics, eKincare functions as India's first personal health assistant, offering a comprehensive range of online and offline healthcare services. These services include 24/7 access to medical consultations, health check-ups, medicine purchases and delivery, health coaching, mental wellness programs, and fitness services. The platform also enables users to monitor their medical information and receive tailored recommendations on healthcare interventions, thereby helping them identify potential health risks and take proactive measures to improve their overall well-being. Trusted by numerous Fortune 500 companies, eKincare aims to redefine healthcare accessibility and management.

Beta Drugs

Post in 2024
Beta Drugs is a pharmaceutical company focused on developing and marketing oncology medications. The company specializes in drug delivery systems designed to enhance patient compliance, simplify usage, prevent dosing errors, and minimize drug waste. Beta Drugs manufactures a variety of products, including tablets, capsules, oral formulations, and injections, primarily for the Indian market, while also exporting its products to other countries.

Redcliffe Labs

Series C in 2024
Redcliffe Labs is a diagnostics service provider focused on identifying both communicable and non-communicable diseases through advanced radiography and pathology services. The company offers a comprehensive range of standard and specialized tests, utilizing cutting-edge laboratories and in-house technology. Redcliffe Labs aims to enhance accessibility to health tests for all individuals in India by leveraging its trusted radiology network and innovative testing methodologies. Additionally, the company specializes in reproductive health testing, cancer gene diagnosis, and screening for rare diseases, ensuring patients receive thorough support, including regular counseling and clinical data management. Through its extensive testing capabilities, Redcliffe Labs is committed to addressing various aspects of health, pregnancy, and fertility care.

Red.Health

Series B in 2024
Red.Health is a healthcare services provider that specializes in emergency medical services, focusing on private ambulance services to enhance patient experiences throughout the emergency value chain. The company offers a diverse range of services including ambulance transportation, telemedicine, and emergency response solutions. Its ambulances are equipped with advanced diagnostic tools and come in various configurations, such as basic, advanced, and medical utility vehicles, tailored to meet specific medical needs. This ensures that patients receive prompt medical transport within minutes, accompanied by trained personnel.

CureSkin

Series B in 2024
CureSkin is a Bengaluru-based company founded in 2016 that specializes in AI-powered mobile applications for dermatological care. The app utilizes computer vision technology to analyze user-uploaded photos, identifying various skin issues such as acne, dark spots, scars, and pigmentation. Based on the analysis, CureSkin recommends personalized treatment plans, skincare products, and connects users with dermatologists for follow-up consultations. By offering these services, CureSkin aims to provide accessible and effective skin health solutions, particularly for individuals who may not have easy access to trained professionals.

HealthifyMe

Series D in 2023
HealthifyMe is a fitness application designed to help users achieve their health and weight loss objectives through their computers and smartphones. Launched in 2012 by a team of doctors, nutritionists, and fitness trainers in Bangalore, India, the app allows users to track their calorie intake, monitor nutrition and fitness activities, and assess their weight to determine overall health. With features that enable users to set and work towards healthy goals, the platform also facilitates data sharing with experts, who provide personalized advice and recommendations. The application is enhanced by an artificial intelligence-powered fitness coach that leverages automated analytics, making it easier for users to receive tailored online fitness consultations and achieve their health aspirations.

The Healthy Billion

Venture Round in 2023
THB is a prominent clinical intelligence company based in Gurugram, Haryana, founded in 2015. The company focuses on leveraging real-world evidence to enhance the healthcare ecosystem through advanced data technology solutions. By offering clinical and business modules, THB aims to improve patient outcomes and shift the healthcare industry towards data and evidence-based decision-making. With a presence in over 50 cities across more than 12 states in India, THB is dedicated to enabling data-driven healthcare and enhancing customer experience in the sector.

Technology Healthcare Big Data Analytics

Venture Round in 2023
THB is a healthcare data-technology and analytics platform enhancing decision-making and patient outcomes.

BeatO

Series B in 2022
BeatO is a health technology company that specializes in developing a comprehensive health monitoring application aimed at assisting diabetic patients in managing their condition. Founded in 2015 by Gautam Chopra, Yash Sehgal, Kunal Kinalekar, and Abhishek Kumar, the company is based in New Delhi, Delhi. BeatO's application offers a full-stack diabetes management program that enables users to track their glucose levels, manage their diet, exercise, medication intake, and receive diagnosis support. The platform features an online glucometer that records glucose readings and connects patients with healthcare professionals for real-time guidance, particularly when readings deviate from normal levels. By providing essential tools for self-management, BeatO empowers diabetic patients to maintain better control over their health.

Wysa

Series B in 2022
Wysa is a mental health wellness platform designed to assist individuals in managing stress related to social isolation and health anxiety. The platform features an AI chatbot that utilizes evidence-based cognitive-behavioral techniques to provide users with medical guidance and digital self-help resources. It also offers messaging support from professional therapists and counselors, facilitating personalized care pathways for users. By combining AI-driven support with human expertise, Wysa aims to deliver proactive behavioral health assistance directly to users' mobile devices, ensuring accessible and tailored interventions for those in need.

GoApptiv

Series A in 2022
GoApptiv provides comprehensive go-to-market solutions for pharmaceutical companies in India, focusing on enhancing healthcare access in extra-urban and rural areas. The company has developed a suite of healthcare software that includes a digital payment and promotional platform, a doctor-patient engagement platform, and a data analytics platform. By leveraging proprietary data analytics tools and a network of distribution partners, GoApptiv aims to facilitate agile market access and optimize patient experiences. This approach supports organizational growth and empowers stakeholders within the healthcare ecosystem, ensuring a cost-effective and efficient entry into the market.

Redcliffe Labs

Series B in 2022
Redcliffe Labs is a diagnostics service provider focused on identifying both communicable and non-communicable diseases through advanced radiography and pathology services. The company offers a comprehensive range of standard and specialized tests, utilizing cutting-edge laboratories and in-house technology. Redcliffe Labs aims to enhance accessibility to health tests for all individuals in India by leveraging its trusted radiology network and innovative testing methodologies. Additionally, the company specializes in reproductive health testing, cancer gene diagnosis, and screening for rare diseases, ensuring patients receive thorough support, including regular counseling and clinical data management. Through its extensive testing capabilities, Redcliffe Labs is committed to addressing various aspects of health, pregnancy, and fertility care.

Medikabazaar

Series D in 2022
Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.

Qure AI

Series C in 2022
Qure.ai Technologies Private Limited specializes in developing artificial intelligence software for the healthcare sector, focusing on medical imaging to enhance disease diagnosis from radiology and pathology images. Founded in 2016 and headquartered in Mumbai, India, with a presence in New York, the company offers tools such as qXR, which automates chest X-ray interpretation to identify abnormal findings, including signs of tuberculosis. Qure.ai also provides qER, which assists in triaging critical head CT scans and offers tools for monitoring traumatic brain injury and reporting. By leveraging deep learning solutions, Qure.ai aims to improve the accuracy of diagnoses and make healthcare more affordable and accessible, ultimately allowing healthcare professionals to dedicate more time to patient care.

eKincare

Series B in 2022
eKincare is an AI-powered integrated health benefits platform that delivers preventive, predictive, and personalized healthcare solutions for organizations and their employees. By leveraging technology and analytics, eKincare functions as India's first personal health assistant, offering a comprehensive range of online and offline healthcare services. These services include 24/7 access to medical consultations, health check-ups, medicine purchases and delivery, health coaching, mental wellness programs, and fitness services. The platform also enables users to monitor their medical information and receive tailored recommendations on healthcare interventions, thereby helping them identify potential health risks and take proactive measures to improve their overall well-being. Trusted by numerous Fortune 500 companies, eKincare aims to redefine healthcare accessibility and management.

CureSkin

Series A in 2022
CureSkin is a Bengaluru-based company founded in 2016 that specializes in AI-powered mobile applications for dermatological care. The app utilizes computer vision technology to analyze user-uploaded photos, identifying various skin issues such as acne, dark spots, scars, and pigmentation. Based on the analysis, CureSkin recommends personalized treatment plans, skincare products, and connects users with dermatologists for follow-up consultations. By offering these services, CureSkin aims to provide accessible and effective skin health solutions, particularly for individuals who may not have easy access to trained professionals.

Red.Health

Series A in 2022
Red.Health is a healthcare services provider that specializes in emergency medical services, focusing on private ambulance services to enhance patient experiences throughout the emergency value chain. The company offers a diverse range of services including ambulance transportation, telemedicine, and emergency response solutions. Its ambulances are equipped with advanced diagnostic tools and come in various configurations, such as basic, advanced, and medical utility vehicles, tailored to meet specific medical needs. This ensures that patients receive prompt medical transport within minutes, accompanied by trained personnel.

Medikabazaar

Series C in 2021
Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.

HealthifyMe

Series C in 2021
HealthifyMe is a fitness application designed to help users achieve their health and weight loss objectives through their computers and smartphones. Launched in 2012 by a team of doctors, nutritionists, and fitness trainers in Bangalore, India, the app allows users to track their calorie intake, monitor nutrition and fitness activities, and assess their weight to determine overall health. With features that enable users to set and work towards healthy goals, the platform also facilitates data sharing with experts, who provide personalized advice and recommendations. The application is enhanced by an artificial intelligence-powered fitness coach that leverages automated analytics, making it easier for users to receive tailored online fitness consultations and achieve their health aspirations.

Medikabazaar

Series B in 2019
Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.

Medikabazaar

Series B in 2019
Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.

Hi Impact

Venture Round in 2019
Hi Impact is a healthcare staffing company in India that focuses on connecting prospective doctors with healthcare employers. The company operates a platform that facilitates placements in hospitals, diagnostic centers, and private medical colleges across the country. By aligning candidates with suitable positions based on their qualifications and eligibility, Hi Impact aims to support both healthcare professionals and employers in achieving their goals. The company emphasizes that its success is intertwined with the success of its clients and candidates, reflecting its commitment to fostering positive outcomes in the healthcare sector.

Asian Institute Of Nephrology And Urology

Venture Round in 2019
Asian Institute of Nephrology and Urology Private Limited is a specialized renal sciences hospital located in Hyderabad, India. Founded in 2011, the institute focuses on providing comprehensive medical and surgical services related to nephrology and urology. It offers a range of treatments for acute, chronic, and end-stage renal diseases, along with day care and supportive services, including anesthesiology and radiology. The hospital aims to deliver high-quality patient care through its dedicated clinical services, ensuring that patients receive specialized attention for their urological and nephrological needs.

Medikabazaar

Series A in 2018
Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.

The Healthy Billion

Venture Round in 2018
THB is a prominent clinical intelligence company based in Gurugram, Haryana, founded in 2015. The company focuses on leveraging real-world evidence to enhance the healthcare ecosystem through advanced data technology solutions. By offering clinical and business modules, THB aims to improve patient outcomes and shift the healthcare industry towards data and evidence-based decision-making. With a presence in over 50 cities across more than 12 states in India, THB is dedicated to enabling data-driven healthcare and enhancing customer experience in the sector.

Strand Life Sciences

Private Equity Round in 2018
Strand Life Sciences Pvt Ltd. is a clinical diagnostics and genomic profiling company based in Bengaluru, India, specializing in the development and marketing of diagnostic tests for cancer and inherited diseases. Founded in 2000, the company offers a wide range of services, including diagnostics for oncology, genetics, fertility, women's health, infectious diseases, and general wellness. Strand provides advanced bioinformatics solutions, such as variant curation and interpretation platforms, along with its StrandOmics software for actionable insights from genomic data. The firm operates a DNA sequencing lab and has established partnerships with over 100 hospitals in India, expanding its reach into the US market. Strand's innovative software, including GeneSpring and Avadis, is utilized by 1,400 research institutions worldwide. The company emphasizes personalized medicine by identifying hereditary cancer risks and enabling tailored surveillance and risk-reduction strategies for patients. With a team of approximately 200 employees, Strand Life Sciences continues to grow in response to increasing demand for its genomic testing and interpretation services.

Asian Institute Of Nephrology And Urology

Series A in 2017
Asian Institute of Nephrology and Urology Private Limited is a specialized renal sciences hospital located in Hyderabad, India. Founded in 2011, the institute focuses on providing comprehensive medical and surgical services related to nephrology and urology. It offers a range of treatments for acute, chronic, and end-stage renal diseases, along with day care and supportive services, including anesthesiology and radiology. The hospital aims to deliver high-quality patient care through its dedicated clinical services, ensuring that patients receive specialized attention for their urological and nephrological needs.

Regency Healthcare

Venture Round in 2017
Regency Healthcare which started as Regency Hospital was the first, Multi-Specialty Tertiary Care Corporate Hospital in Uttar Pradesh. The Hospital was established in 1995 with a view to fill the wide gap between the demand of high quality medical services and actually available services on ground. In a span of 20 years, the hospital has been able to establish a distinct identity for delivering super specialty medical services to Kanpur, surrounding cities & rural areas.

Neurosynaptic Communications

Series A in 2016
Neurosynaptic Communications Pvt. Ltd., based in Bangalore, India, specializes in medical diagnostic equipment and solutions aimed at improving healthcare accessibility, particularly for rural populations. Founded in 2002, the company offers a range of products including the ReMeDi-MDAU multi-parameter data acquisition unit, telemedicine software, and various portable diagnostic devices such as ECG machines and pulse oximeters. Additionally, Neurosynaptic provides software solutions for patient diagnosis, prescriptions, lab investigations, and the management of medical records. By leveraging information and communication technology, the company focuses on enhancing healthcare delivery through remote diagnosis and efficient monitoring, ultimately striving to make quality healthcare more affordable and accessible.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.